William Blair Investment Management
AERI

William Blair Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

William Blair Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,807,563
Closed -$12.7M – 466
2021
Q4 		$12.7M Sell
1,807,563
-1,069,586
-37% -$11.2M 0.03% 332
2021
Q3 		$32.8M Buy
2,877,149
+690,649
+32% +$10.1M 0.09% 249
2021
Q2 		$35M Buy
2,186,500
+548,628
+33% +$9.41M 0.11% 167
2021
Q1 		$29.3M Buy
1,637,872
+125,831
+8% +$2.17M 0.09% 187
2020
Q4 		$20.4M Buy
1,512,041
+92,359
+7% +$1.12M 0.07% 210
2020
Q3 		$16.7M Buy
1,419,682
+45,615
+3% +$556K 0.07% 206
2020
Q2 		$20.3M Buy
+1,374,067
New +$20.3M 0.08% 188

Other funds holding AERI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

William Blair Investment Management's AERI Position: Q1 2022 in Review

William Blair Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2022, closing a stake of 1,807,563 shares — an estimated $12.7M sold.

William Blair Investment Management first reported a position in AERI in Q2 2020 and held it in 7 quarters. The position peaked at $35M in Q2 2021. 136 funds tracked by Wall St. Rank hold AERI as of Q1 2022.

  • William Blair Investment Management reported no remaining Aerie Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • William Blair Investment Management sold 1,807,563 Aerie Pharmaceuticals shares in Q1 2022, an estimated $12.7M.
  • William Blair Investment Management first reported a position in Aerie Pharmaceuticals in Q2 2020 and held it in 7 quarters.
  • William Blair Investment Management's Aerie Pharmaceuticals position peaked at $35M in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2022.

Based on William Blair Investment Management's 13F filing for Q1 2022, filed 11 May 2022.